МИНИМИЗАЦИЯ КОГНИТИВНЫХ НАРУШЕНИЙ ПРИ ЭЛЕКТРОСУДОРОЖНОЙ ТЕРАПИИ: РЕАЛИИ И ПЕРСПЕКТИВЫ (ОБЗОР ЛИТЕРАТУРЫ С КОММЕНТАРИЯМИ И РЕКОМЕНДАЦИЯМИ) (I ЧАСТЬ: ТЕОРЕТИЧЕСКАЯ)

Yuriy Vitalevich Bykov, Roman Aleksandrovich Bekker


Аннотация


Электросудорожная терапия (ЭСТ) является высокоэффективным и безопасным методом лечения психических заболеваний, особенно расстройств аффективной сферы. Однако её применение может быть сопряжено с развитием когнитивных нарушений (КН), в частности нарушений памяти, что снижает как терапевтическую эффективность ЭСТ, так и комплаентность больных к ней. В силу этого, минимизация КН имеет важное значение в практике ЭСТ, как для повышения её терапевтической эффективности, так и для повышения комплаентности больных. В настоящем обзоре, в его первой части, мы рассматриваем различные гипотезы о патофизиологии КН при ЭСТ и вытекающие из них меры по минимизации КН.


Ключевые слова


электросудорожная терапия; когнитивные нарушения; ретроградная амнезия; антероградная амнезия; депрессивные нарушения; патофизиология когнитивных нарушений

Полный текст:

PDF>PDF

Литература


Беккер Р.А., Быков Ю.В. О роли нейроэндокринных нарушений в патогенезе когнитивной дисфункции при депрессивных состояниях (обзор литературы с комментариями). Consilium Medicum. 2016;04:57-61.

Нельсон А.И. Электросудорожная терапия в психиатрии, наркологии и неврологии. М.: БИНОМ. Лаборатория знаний, 2005. 368 с.

Нуллер Ю.Л. Депрессия и деперсонализация. Л.: Медицина, 1981. 207 с.

Резников М.К., Беккер Р.А., Быков Ю.В. Преодоление фармакорезистентности при депрессии на фоне выраженной гиперкортизолемии: обзор литературы и клинический случай. В мире научных открытий. 2016;6:24-44.

Abrams R. Electroconvulsive Therapy.4th ed. New York, NY; Oxford, UK: Oxford University Press. 2002. 328 р.

Adam LA, Crowe RR. Use of ECT in idiopathic intracranial hypertension. J ECT. 2003;19(4):234-7.

Anand A, Andrade C, Sudha S et al. Phenylephrine and ECS-induced retrograde amnesia. J ECT. 2001;17(3):166-9.

Andrade C, Shaikh SA, Narayan L et al. Administration of a selective glucocorticoid antagonist attenuates electroconvulsive shock-induced retrograde amnesia. J Neural Transm (Vienna). 2012;119(3):337-44.

Andrade C, Singh NM, Thyagarajan S et al. glutamatergic and lipid signalling mechanisms in ECT-induced retrograde amnesia: Experimental evidence for involvement of COX-2 and review of literature. J Psychiatr Res. 2008;42:837–50.

Andrade C, Bolwig TG. Electroconvulsive therapy, hypertensive surge, blood-brain barrier breach, and amnesia: exploring the evidence for a connection. J ECT. 2014;30(2):160-4.

Andrade C. ECT and cardiovascular disorders. Arch Indian Psychiatry. 1995; 2:105–9.

Andrade C. ECT, hypertensive mechanisms and cognitive dysfunction. Indian J Psychol Med. 2000;23:40–1.

Ayuso-Gutierrez JL, Saiz-Ruiz J. The value of cytidine-5-diphosphate-choline in the prevention of impairment of memory function after electric convulsive therapy. A double-blind study. Prog Neuropsychopharmacol Biol Psychiatry. 1982;6(3):243-8.

Baghai TC, Eser D, Schüle C et al. Elektrokonvulsionstherapie bei depressiven Störungen. Journal für Neurologie, Neurochirurgie und Psychiatrie. 2005;4:20–8.

Baghai TC, Möller HJ. Electroconvulsive therapy and its different indications. Dialogues Clin Neurosci. 2008;10(1):105-17.

Benson-Martin JJ, Stein DJ, Baldwin DS et al. Genetic mechanisms of electroconvulsive therapy response in depression. Hum Psychopharmacol. 2016;31(3):247-51.

Bousman CA, Katalinic N, Martin DM et al. Effects of COMT, DRD2, BDNF, and APOE Genotypic Variation on Treatment Efficacy and Cognitive Side Effects of Electroconvulsive Therapy. J ECT. 2015;31(2):129-35.

Bowdler JM, Green AR, Rawle F. Brain and serum calcium concentrations following electroconvulsive shock or bicuculline-induced convulsions in rats. Br J Pharmacol. 1980;71(1):321-5.

Brakemeier EL, Berman R, Prudic J et al. Self-evaluation of the cognitive effects of electroconvulsive therapy. J ECT. 2011;27:59–66.

Calev A, Cohen R, Tubi N et al. Disorientation and bilateral moderately suprathreshold titrated ECT. Convulsive Therapy 1991; 7: 99-110.

Calev A, Fink M, Petrides G et al. Caffeine Pretreatment Enhances Clinical Efficacy and Reduces Cognitive Effects of Electroconvulsive Therapy. Convuls Ther. 1993;9(2):95-100.

Carman JS, Post RM, Goodwin FK et al. Calcium and electroconvulsive therapy of severe depressive illness. Biol Psychiatry. 1977;12(1):5-17.

Chamberlin E, Tsai GE. A glutamatergic model of ECT-induced memory dysfunction. Harv Rev Psychiatry. 1998;5(6):307-17.

Dagytė G, Den Boer JA, Trentani A.The cholinergic system and depression.Behav Brain Res. 2011;221(2):574-82.

Daniel W F, Crovitz HF. Recovery of orientation after electroconvulsive therapy. Acta Psychiatrica Scandinavica 1982;66:421-8.

Davidson J, McLeod M, Law-Yone B, Linnoila M. A comparison of electroconvulsive therapy and combined phenelzine-amitriptyline in refractory depression. Arch Gen Psychiatry. 1978;35:639–642.

Derikx RL, van Waarde JA, Verwey B et al. Effects on intracranial pressure of electroconvulsive therapy. J ECT. 2012;28(2):e23-4.

ECT review group. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet. 2003;361:799–808.

Esel E, Kose K, Hacimusalar Y et al. The effects of electroconvulsive therapy on GABAergic function in major depressive patients.J ECT. 2008;24(3):224-8.

Fakhri O, Fadhli AA, el Rawi RM. Effect of electroconvulsive therapy on diabetes mellitus. Lancet. 1980;2(8198):775-7.

Fink M. Complaints of loss of personal memories after electroconvulsive therapy: evidence of a somatoform disorder? Psychosomatics. 2007;48(4):290-3.

Fond G, Hamdani N, Kapczinski F et al. Effectiveness and tolerance of anti-inflammatory drugs’ add-on therapy in major mental disorders: a systematic qualitative review.Acta Psychiatr Scand. 2014;129(3):163-79.

Food and Drug Administration. Meeting to discuss the classification of electroconvulsive therapy devices (ECT). FDA Executive Summary. January 27–28, 2011.

Fraser LM, O’Carroll RE, Ebmeier KP. The effect of electroconvulsive therapy on autobiographical memory: A systematic review. Journal of ECT. 2008;24(1):10–7.

Ghaziuddin N, Laughrin D, Giordani B. Cognitive side effects of electroconvulsive therapy in adolescents. J Child Adolesc Psychopharmacol. 2000;10:269–276.

Gregory-Roberts EM, Naismith SL, Cullen KM, Hickie IB. Electroconvulsive therapy-induced persistent retrograde amnesia: could it be minimised by ketamine or other pharmacological approaches? J Affect Disord. 2010;126:39–45.

Harish K, Kumar BP, Lal TK. Correlation of oxygen saturation and amnesia during modified conventional electro convulsive therapy. Indian J. Anaesth. 2002; 46(2):130-3.

Ingram A, Saling MM, Schweitzer I. Cognitive side effects of brief pulse electroconvulsive therapy: A review. J ECT. 2008;24:3–9.

Jarvie H, Mulligan L. Serum calcium levels after ECT modified with scoline. Am J Psychiatry. 1959;115(10):933-4.

Jenike MA. ECT and diabetes mellitus. Am J Psychiatry. 1982;139(1):136.

Kamath S, Andrade C, Faruqi S et al. Evaluation of pre-ECS antihypertensive drug administration in the attenuation of ECS-induced retrograde amnesia. Convuls Ther. 1997;13(3):185-95.

Kargar M, Yoosefi A, Akhondzadeh S et al. Effect of Adjunctive Celecoxib on BDNF in Manic Patients Undergoing Electroconvulsive Therapy: a Randomized Double Blind Controlled Trial. Pharmacopsychiatry. 2015;48(7):268-73.

Kargar M, Yousefi A, Mojtahedzadeh M et al. Effects of celecoxib on inflammatory markers in bipolar patients undergoing electroconvulsive therapy: a placebo-controlled, double-blind, randomised study. Swiss Med Wkly. 2014;144:w13880.

Kerner N, Prudic J. Current electroconvulsive therapy practice and research in the geriatric population. Neuropsychiatry (London). 2014;4(1):33-54.

Krause P, Genz A, Knorr W. [Prospective study of the late sequelae of electroconvulsive treatment]Psychiatrie, Neurologie und medizinische Psychologie. 1988;40:532–6.

Leung M, Hollander Y, Brown GR. Pretreatment with ibuprofen to prevent electroconvulsive therapy-induced headache. J Clin Psychiatry. 2003; 64(5):551-3.

Lisanby SH, Maddox JH, Prudic J et al. The effects of electroconvulsive therapy on memory of autobiographical and public events. Archives of General Psychiatry. 2000;57(6):581–590.

Matthews JD, Siefert CJ, Blais MA. A double-blind, placebo-controlled study of the impact of galantamine on anterograde memory impairment during electroconvulsive therapy. J ECT. 2013;29(3):170-8.

Mayur P, Byth K, Harris A. Autobiographical and subjective memory with right unilateral high-dose 0.3-millisecond ultrabrief-pulse and 1-millisecond brief-pulse electroconvulsive therapy: A double-blind, randomized controlled trial. J ECT. 2013;29:277–82.

McClintock S, Staub B, Husain M. The effects of electroconvulsive therapy on neurocognitive function in elderly adults. Annals of Long-Term Care: Clinical Care and Aging. 2011;19(3):32–8.

McClintock SM, Choi J, Deng ZD et al. Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy. J ECT. 2014;30(2):

-76.

Mehta A, Prabhakar M, Kumar P et al. Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur J Pharmacol. 2013;698(1-3):6-18.

Merk W, Kucia K. Combined use of ECT and psychotropic drugs. [Article in English, Polish]. Psychiatr Pol. 2015;49(6):1241-53.

Minelli A, Congiu C, Ventriglia M et al. Influence of GRIK4 genetic variants on the electroconvulsive therapy response. Neurosci Lett. 2016;626:94-8.

Mohammad-Zadeh LF, Moses L, Gwaltney-Brant SM. Serotonin: a review.J Vet Pharmacol Ther. 2008;31(3):187-99.

Muthuramalingam A, Menon V, Rajkumar RP, Negi VS. Is Depression an Inflammatory Disease? Findings from a Cross-Sectional Study at a Tertiary Care Center.Indian J Psychol Med. 2016;38(2):114-9.

Nagaraja N, Andrade C, Sudha S et al. Glucocorticoid mechanisms may contribute to ECT-induced retrograde amnesia. Psychopharmacology (Berl) 2007;190:83–90.

Neylan TC, Canick JD, Hall SE, Cortisol levels predict cognitive impairment induced by electroconvulsive therapy. Biol Psychiatry. 2001;50(5):331-6.

Nobler MS, Sackeim HA. Neurobiological correlates of the cognitive side effects of electroconvulsive therapy. Journal of ECT. 2008;24(1):40–5.

O’Brien DR. The effective agent in electroconvulsive therapy: convulsion or coma? Med Hypotheses. 1989;28(4):277-80.

Pandya M, Pozuelo L, Malone D. Electroconvulsive therapy: what the internist needs to know. Cleve Clin J Med. 2007;74(9):679–685.

Papakostas GI. Cognitive symptoms in patients wtih major depressive disorder and their implications for clinical practice. Journal of Clinical Psychiatry. 2014;75(1):8–14.

Payne NA, Prudic J. Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT. J Psychiatr Pract. 2009;15(5):

-68.

Peng S, Zhang Y, Zhang J, Wang H, Ren B. Glutamate receptors and signal transduction in learning and memory. Mol Biol Rep. 2011;38:453–460.

Peterchev AV, Rosa MA, Deng ZD et al. Electroconvulsive Therapy Stimulus Parameters: Rethinking Dosage. Journal of ECT. 2010;26(3):159–174.

Polyakova M, Schroeter ML, Elzinga BM et al. Brain-derived neurotrophic factor and antidepressive effect of electroconvulsive therapy: systematic review and meta-analyses of the preclinical and clinical literature. PLoS One. 2015;10(11):e0141564.

Porter RJ, Douglas K, Knight RG. Monitoring of cognitive effects during a course of electroconvulsive therapy: Recommendations for clinical practice. J ECT. 2008;24:25–34.

Prakash J, Srivastava K, Manandhar P, Saha A. Evaluation of nonmemory cognitive parameters in psychiatric patients’ pre- and post-electroconvulsive therapy: An observational study. Ind Psychiatry J. 2015;24(2):206-9.

Prudic J, Peyser S, Sackeim HA. Subjective memory complaints: a review of patient self-assessment of memory after electroconvulsive therapy. J. ECT. 2000;16(2):121–132.

Prudic J, Fitzsimons L, Nobler MS, Sackeim HA. Naloxone in the prevention of the adverse cognitive effects of ECT: a within-subject, placebo controlled study. Neuropsychopharmacology. 1999;21(2):285-93.

Prudic J. Strategies to minimize cognitive side effects with ECT: aspects of ECT technique. J ECT. 2008;24(1):46-51.

Quinn DK, Abbott CC. Catatonia after cerebral hypoxia: do the usual treatments apply? Psychosomatics. 2014;55(6):525-35.

Rajagopal R, Chakrabarti S, Grover S. Satisfaction with electroconvulsive therapy among patients and their relatives. J ECT. 2013;29(4):283-90.

Rami-Gonzalez L, Bernardo M, Boget T et al. Subtypes of memory dysfunction associated with ECT: Characteristics and neurobiological bases. J ECT. 2001;17:129–35.

Ramírez N, Arranz B, Dueñas RM, San L. [Electroconvulsive therapy and serotonergic system].[Article in Spanish]. Actas Esp Psiquiatr. 2000;28(5):330-6.

Rao NS, Andrade C, Reddy KP et al. Memory protective effect of indomethacin against electroconvulsive shock-induced retrograde amnesia in rats. Biol Psychiatry.2002;51:770–3.

Reid IC, Stewart CA. Seizures, memory and synaptic plasticity. Seizure. 1997;6:351–9.

Robertson H, Pryor R. Memory and cognitive effects of ECT: Informing and assessing patients. Adv Psychiatr Treat. 2006;12:228–38.

Rose D, Fleischmann P, Wykes T et al. Patients’ perspectives on electroconvulsive therapy: systematic review. BMJ. 2003;326:1363.

Rosen Y, Reznik I, Sluvis A et al. The significance of the nitric oxide in electro-convulsive therapy: a proposed neurophysiological mechanism. Med Hypotheses. 2003;60(3):424-9.

Rotter A, Biermann T, Stark C et al. Changes of cytokine profiles during electroconvulsive therapy in patients with major depression. J ECT. 2013; 29(3):162-9.

Sackeim HA, Prudic J, Devanand DP et al. A prospective, randomized, double-blind comparison of bilateral and right unilateral electroconvulsive therapy at different stimulus intensities. Arch Gen Psychiatry. 2000;57:425–434.

Sackeim HA, Prudic J, Devanand DP et al. Effects of stimulus intensity and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. New England Journal of Medicine. 1993;328:839–846.

Sadek AR, Knight GE, Burnstock G. Electroconvulsive therapy: a novel hypothesis for the involvement of purinergic signalling. Purinergic Signal. 2011;7(4):447-52.

Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry. 2000;57:925–35.

Schat A, van den Broek WW, Mulder PG et al. Changes in everyday and semantic memory function after electroconvulsive therapy for unipolar depression. J ECT. 2007;23:153–7.

Semkovska M, McLoughlin DM. Measuring retrograde autobiographical amnesia following electroconvulsive therapy: Historical perspective and current issues. J ECT. 2013;29:127–33.

Semkovska M, McLoughlin DM. Objective cognitive performance associated with electroconvulsive therapy for depression: a systematic review and meta-analysis. Biol Psychiatry. 2010;68(6):568–577.

Sienaert P. What we have learned about electroconvulsive therapy and its relevance for the practising psychiatrist. Can J Psychiatry. 2011;56(1):

–12.

Sierra M. Depersonalization: A New Look on A Neglected Syndrome. Cambridge Medicine. ISBN 978-0521874984. Cambridge University Press, 2010. 183 p.

Sobin C, Sackeim HA, Prudic J al. Predictors of retrograde amnesia following ECT. American Journal of Psychiatry 1995;152:995-1001.

Sommer BR1, Satlin A, Friedman L, Cole JO. Glycopyrrolate versus atropine in post-ECT amnesia in the elderly. J Geriatr Psychiatry Neurol. 1989;2(1):

-21.

Squire LR, Miller PL. Diminution of anterograde amnesia following electroconvulsive therapy. British Journal of Psychiatry. 1974;125:490–5.

Stanley M, Lerer B.Electroconvulsive Shock and Brain Cholinergic Function: Role of Striatal Muscarinic Receptors.Convuls Ther. 1985;1(3):158-166.

Stewart CS, Jeffrey K, Reid IC. LTP-like synaptic efficacy changes following electroconvulsive therapy. Neuroreport. 1994;5:1041–4.

Stiedl O, Pappa E, Konradsson-Geuken Å, Ögren SO.The role of the serotonin receptor subtypes 5-HT1A and 5-HT7 and its interaction in emotional learning and memory.Front Pharmacol. 2015;6:162.

Stryjer R, Ophir D, Bar F et al. Rivastigmine treatment for the prevention of electroconvulsive therapy-induced memory deficits in patients with schizophrenia. Clin Neuropharmacol. 2012;35(4):161-4.

Sudha S, Andrade C, Anand A et al. Nitroprusside and ECS-induced retrograde amnesia. J ECT. 2001;17(1):41-4.

Sushma M, Sudha S, Guido S.Pre-electroconvulsive shock administration of calcium channel blockers reduces retrograde amnesia induced by ECS.Indian J Exp Biol. 2004;42(11):1141-4.

Svendsen AM, Miskowiak K, Vinberg M. [Risk of long-lasting negative cognitive consequences after electroconvulsive therapy]. [Article in Danish] Ugeskr Laeger. 2013;175(44):2649-50.

Taylor S. Electroconvulsive therapy: a review of history, patient selection, technique and medication management. South Med J. 2007;100(5):

–8.

Thompson AJ, Lummis SC.The 5-HT3 receptor as a therapeutic target.Expert Opin Ther Targets. 2007;11(4):527-40.

Tremont G, Stern RA. Minimizing the cognitive effects of lithium therapy and electroconvulsive therapy using thyroid hormone. Int J Neuropsychopharmacol. 2000;3(2):175-186.

Vamos M. The cognitive side effects of modern ECT: Patient experience or objective measurement? J ECT. 2008;24:18–24.

Weiner R, Lisanby SH, Husain MM, et al. Electroconvulsive therapy device classification: Response to the FDA advisory panel hearing and recommendations. Journal of Clinical Psychiatry. 2013;74(1):38–42.

Yi J, Torres J, Azner Y et al. Flumazenil pretreatment in benzodiazepine-free patients: a novel method for managing declining ECT seizure quality. J ECT. 2012;28(3):185-9.

Zolezzi M. Medication management during electroconvulsant therapy. Neuropsychiatr Dis Treat. 2016;12:931-9.




DOI: https://doi.org/10.12731/wsd-2016-10-54-92

Ссылки

  • На текущий момент ссылки отсутствуют.


Bookmark and Share


(c) 2016 В мире научных открытий



ISSN 2658-6649 (print)

ISSN 2658-6657 (online)

HotLog Яндекс цитирования